Literature DB >> 25941021

Poorly differentiated hepatocellular carcinoma accompanied by anti-Hu antibody-positive paraneoplastic peripheral neuropathy.

Takahiro Matsui1, Yumiko Hori1, Hiroaki Nagano2, Hidetoshi Eguchi2, Shigeru Marubashi2, Hiroshi Wada2, Naoki Wada1, Jun-Ichiro Ikeda1, Michiie Sakamoto3, Eiichi Morii1.   

Abstract

The anti-Hu antibody is one of the most famous onco-neural antibodies related to paraneoplastic neurological syndrome, and is associated with small cell lung carcinoma in most cases. Here, we report a case of poorly differentiated hepatocellular carcinoma accompanied by paraneoplastic peripheral neuropathy positive for the anti-Hu antibody. Image inspection before operation revealed that no tumors were found in organs other than the liver, including lung, and that the liver tumor had no metastatic lesion. The liver tumor showed histological appearance of poorly differentiated carcinoma with cartilaginous metaplasia and partial blastoid cell appearance. Most tumor cells presented trabecular-like structure lined by sinusoidal vessels. Immunohistochemically, the tumor cells were positive for low molecular weight cytokeratin and vimentin, partially positive for cytokeratin 19 and CD56, but negative for synaptophysin, chromogranin A and alpha-fetoprotein. Based on the trabecular-like morphology and the results of immunohistochemical staining, we concluded that the tumor was diagnosed as poorly differentiated hepatocellular carcinoma. Anti-Hu antibody-positive paraneoplastic peripheral neuropathy accompanied with liver tumor is extremely rare as far as is known. The presented case indicates that poorly differentiated carcinoma has the potential to be the responsible lesion of anti-Hu antibody-positive paraneoplastic neurological syndrome and systemic work-up is important for the management of this neurological disorder.
© 2015 Japanese Society of Pathology and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  anti-Hu antibody; paraneoplastic neurological syndrome; poorly differentiated hepatocellular carcinoma

Mesh:

Substances:

Year:  2015        PMID: 25941021     DOI: 10.1111/pin.12304

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  4 in total

Review 1.  Sensory Neuronopathies.

Authors:  Allison Crowell; Kelly G Gwathmey
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08-23       Impact factor: 5.081

Review 2.  Subacute sensory neuronopathy associated with Merkel cell carcinoma with unknown primary: a case report with literature review.

Authors:  Riccardo Milani; Miryam Cannizzaro; Gianluigi Arrigoni; Federica Filipello; Federica Cerri; Massimo Filippi
Journal:  J Neurol       Date:  2022-04-16       Impact factor: 6.682

3.  Severe digital ischemia coexists with thrombocytopenia in malignancy-associated antiphospholipid syndrome: A case report and review of literature.

Authors:  Jia-Lei Chen; Xi Yu; Rong Luo; Ming Liu
Journal:  World J Clin Cases       Date:  2021-12-26       Impact factor: 1.337

Review 4.  Atezolizumab-induced Encephalitis in a Patient with Hepatocellular Carcinoma: A Case Report and Literature Review.

Authors:  Tomoyuki Satake; Yuta Maruki; Yuko Kubo; Masamichi Takahashi; Akihiro Ohba; Yoshikuni Nagashio; Shunsuke Kondo; Susumu Hijioka; Chigusa Morizane; Hideki Ueno; Takuji Okusaka
Journal:  Intern Med       Date:  2022-02-19       Impact factor: 1.282

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.